167 related articles for article (PubMed ID: 38781924)
1. Trends in Nationally Notifiable Infectious Diseases in Humans and Animals during COVID-19 Pandemic, South Korea.
Chang T; Cho SI; Yoo DS; Min KD
Emerg Infect Dis; 2024 Jun; 30(6):1154-1163. PubMed ID: 38781924
[TBL] [Abstract][Full Text] [Related]
2. Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic.
Geng MJ; Zhang HY; Yu LJ; Lv CL; Wang T; Che TL; Xu Q; Jiang BG; Chen JJ; Hay SI; Li ZJ; Gao GF; Wang LP; Yang Y; Fang LQ; Liu W
Nat Commun; 2021 Nov; 12(1):6923. PubMed ID: 34836947
[TBL] [Abstract][Full Text] [Related]
3. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia.
Adegbija O; Walker J; Smoll N; Khan A; Graham J; Khandaker G
Commun Dis Intell (2018); 2021 Feb; 45():. PubMed ID: 33632091
[TBL] [Abstract][Full Text] [Related]
4. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?
Oh KB; Doherty TM; Vetter V; Bonanni P
Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786
[TBL] [Abstract][Full Text] [Related]
5. Effect of COVID-19 on Tuberculosis Notification, South Korea.
Kwak N; Hwang SS; Yim JJ
Emerg Infect Dis; 2020 Oct; 26(10):2506-2508. PubMed ID: 32672531
[TBL] [Abstract][Full Text] [Related]
6. Trends in Viral Respiratory Infections During COVID-19 Pandemic, South Korea.
Yum S; Hong K; Sohn S; Kim J; Chun BC
Emerg Infect Dis; 2021; 27(6):1685-1688. PubMed ID: 34013875
[TBL] [Abstract][Full Text] [Related]
7. Persistence and Variation of the Indirect Effects of COVID-19 Restrictions on the Spectrum of Notifiable Infectious Diseases in China: Analysis of National Surveillance Among Children and Adolescents From 2018 to 2021.
Chen L; Wang L; Xing Y; Xie J; Su B; Geng M; Ren X; Zhang Y; Liu J; Ma T; Chen M; Miller JE; Dong Y; Song Y; Ma J; Sawyer S
JMIR Public Health Surveill; 2024 May; 10():e47626. PubMed ID: 38748469
[TBL] [Abstract][Full Text] [Related]
8. Impact of Nonpharmaceutical Interventions on the Incidence of Respiratory Infections During the Coronavirus Disease 2019 (COVID-19) Outbreak in Korea: A Nationwide Surveillance Study.
Huh K; Jung J; Hong J; Kim M; Ahn JG; Kim JH; Kang JM
Clin Infect Dis; 2021 Apr; 72(7):e184-e191. PubMed ID: 33150393
[TBL] [Abstract][Full Text] [Related]
9. Non-pharmaceutical interventions for COVID-19 reduced the incidence of infectious diseases: a controlled interrupted time-series study.
Zhang W; Wu Y; Wen B; Zhang Y; Wang Y; Yin W; Sun S; Wei X; Sun H; Zhang Z; Li S; Guo Y
Infect Dis Poverty; 2023 Mar; 12(1):15. PubMed ID: 36895021
[TBL] [Abstract][Full Text] [Related]
10. The COVID-19 epidemic and other notifiable infectious diseases in China.
Bai BK; Jiang QY; Hou J
Microbes Infect; 2022 Feb; 24(1):104881. PubMed ID: 34419605
[TBL] [Abstract][Full Text] [Related]
11. Trends in gastrointestinal infections before and during non-pharmaceutical interventions in Korea in comparison with the United States.
Kim S; Kim J; Choi BY; Park B
Epidemiol Health; 2022; 44():e2022011. PubMed ID: 34990526
[TBL] [Abstract][Full Text] [Related]
12. Household Secondary Attack Rates of SARS-CoV-2 Omicron Variant, South Korea, February 2022.
Lim DS; Choe YJ; Man Kim Y; Lee SE; Jang EJ; Kim J; Park YJ
Emerg Infect Dis; 2022 Aug; 28(8):1731-1734. PubMed ID: 35798007
[TBL] [Abstract][Full Text] [Related]
13. Infectious Respiratory Diseases Decreased during the COVID-19 Pandemic in South Korea.
Kim DH; Nguyen TM; Kim JH
Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34205018
[TBL] [Abstract][Full Text] [Related]
14. Rhinovirus Incidence Rates Indicate We Are Tired of Non-pharmacological Interventions Against Coronavirus Disease 2019.
Kim MC; Park JH; Choi SH; Chung JW
J Korean Med Sci; 2022 Jan; 37(2):e15. PubMed ID: 35014227
[TBL] [Abstract][Full Text] [Related]
15. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Medical Use of Military Hospitals in Korea.
Yoon D; Kim KE; Lee JE; Kim M; Kim JH
J Korean Med Sci; 2021 Jul; 36(28):e204. PubMed ID: 34282607
[TBL] [Abstract][Full Text] [Related]
16. Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19.
Chen B; Wang M; Huang X; Xie M; Pan L; Liu H; Liu Z; Zhou P
Front Public Health; 2021; 9():728768. PubMed ID: 34722440
[No Abstract] [Full Text] [Related]
17. A Silver Lining? Fewer Non-Severe Acute Respiratory Syndrome Coronavirus 2 Respiratory Viruses During the Coronavirus Disease 2019 Pandemic.
Most ZM; Holcomb M; Jamieson AR; Perl TM
J Infect Dis; 2021 Nov; 224(10):1751-1755. PubMed ID: 33830238
[TBL] [Abstract][Full Text] [Related]
18. Changes in the Incidence of Intussusception and Infectious Diseases After the COVID-19 Pandemic in Korea.
Yoo IH; Kang HM; Jeong DC
J Korean Med Sci; 2022 Feb; 37(8):e60. PubMed ID: 35226418
[TBL] [Abstract][Full Text] [Related]
19. The indirect impacts of nonpharmacological COVID-19 control measures on other infectious diseases in Yinchuan, Northwest China: a time series study.
Liu W; Wang R; Li Y; Zhao S; Chen Y; Zhao Y
BMC Public Health; 2023 Jun; 23(1):1089. PubMed ID: 37280569
[TBL] [Abstract][Full Text] [Related]
20. Coronavirus Disease Exposure and Spread from Nightclubs, South Korea.
Kang CR; Lee JY; Park Y; Huh IS; Ham HJ; Han JK; Kim JI; Na BJ;
Emerg Infect Dis; 2020 Oct; 26(10):2499-2501. PubMed ID: 32633713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
